ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia

@article{Mielcarek2002ABOIA,
  title={ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia},
  author={Marco Mielcarek and Beverly J Torok-Storb and Rainer F Storb},
  journal={Bone Marrow Transplantation},
  year={2002},
  volume={30},
  pages={547-548}
}
We read with interest the recent report by Mehta et al in which the authors concluded that relapse rates and eventfree survival in patients with acute myeloid leukemia (AML) in first remission were superior after ABO-incompatible compared with ABO-compatible HLA-matched related donor bone marrow transplantation (actuarial 5-year probability of relapse, 12% vs 33%; P = 0.028). Their conclusions were based upon retrospective analysis of data from 119 patients conditioned with cyclophosphamide (n… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Engraftment and transfusion requirements after allogeneic marrow transplanResponse to Mielcarek et al

FB Petersen, M Banaji
Bone Marrow Transplantation • 2002

Graft - versushost disease and donordirected hemagglutinin titers after ABOmismatched related and unrelated marrow allografts : evidence for a graftversusplasma cell effect

M Mielcarek, W Leisenring, B Torok-Storb
Blood • 2000

Similar Papers

Loading similar papers…